Skip to main
BBOT
BBOT logo

BridgeBio Oncology Therapeutics Inc (BBOT)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy BBOT Stock

About BridgeBio Oncology Therapeutics Inc (BBOT)

Bridgebio Oncology Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
Market cap$923.07M
Today's volume65.12K
Revenue (TTM)
Avg. daily volume239.69K
EBITDA (TTM)-$52.53M
Open$12
Price / earnings ratio-12.44x
Today's range$11.9 - $12.83
Debt / equity0.65x
52 week range$8.7 - $14.04
5 year debt / equity
Beta (LTM)3.12x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio13.33x
Ex-dividend date
Next earningsFeb 26, 2026
Dividend payable date

BBOT Stock Rating

What analysts recommend for BBOT stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for BBOT stock is $923.07M

The current P/E ratio for BBOT stock is -12.44

The 52-week high for BBOT stock is $14.04. The current BBOT stock price $undefined is 100.00% below its 52-week high

The 52-week low for BBOT stock is $8.70. The current BBOT stock price $undefined has increased 100.00% from its 52-week low

No, the BBOT stock does not pay dividends to its shareholders

The target price for BBOT stock is $24.75 based on the average of what a group of analyst think BBOT stock could be worth at a future date. This is not a prediction by Public.com

How to buy BBOT stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in BBOT stock

    Navigate to the Explore page. Then, type BBOT into the search bar. When you see BBOT stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased BBOT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

BridgeBio Oncology Therapeutics Inc Stock Earnings

The value each BBOT share was expected to gain vs. the value that each BBOT share actually gained.

BBOT (BBOT) reported Q3 2025 earnings per share (EPS) of -$1.03, missing estimates of -$0.37 by 178.38%. In the same quarter last year, BBOT's earnings per share (EPS) was $0. BBOT is expected to release next earnings on 02/26/2026, with an earnings per share (EPS) estimate of -$0.48.

Buy BBOT Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.